treatment of immunoglobulin G4-related disease
All entries for: Horizon Therapeutics Ireland DAC
May 1, 2026
Horizon Therapeutics Ireland DAC
Orphan Drug Designation
Disease Area: Rare Diseases
treatment of immunoglobulin G4-related disease